Keeping it in check: Chronic viral infection and antiviral immunity in the brain

Nature Reviews Neuroscience

Volumn 17, Issue 12, 2016, Pages 766-776

  Miller, Katelyn D ^a,b   Schnell, Matthias J ^c   Rall, Glenn F ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; VIRUS RNA;

ANTIGEN PRESENTATION; BRAIN INFECTION; BRAIN REGION; CELLULAR IMMUNITY; CHRONIC VIRAL INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS ENTRY; VIRUS GENOME; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS TRANSMISSION; ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM DISEASE; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; RNA VIRUS; RNA VIRUS INFECTION;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; IMMUNITY, INNATE; NEURONS; RNA VIRUS INFECTIONS; RNA VIRUSES;

EID: 84994067093     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn.2016.140     Document Type: Review

References (118)

1. Paludan, S. R., Bowie, A. G., Horan, K. A. & Fitzgerald, K. A. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11, 143-154 (2011).
2. Jones, C. A. et al. Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J. Virol. 77, 11139-11149 (2003).
3. Braaten, D. C., Sparks-Thissen, R. L., Kreher, S., Speck, S. H. & Virgin, H. W. An optimized CD8+ Tcell response controls productive and latent gammaherpesvirus infection. J. Virol. 79, 2573-2583 (2005).
4. Koyuncu, O. O., Hogue, I. B. & Enquist, L. W. Virus infections in the nervous system. Cell Host Microbe 13, 379-393 (2013).
5. Dittmar, S. et al. Measles virus-induced block of transendothelial migration of T lymphocytes and infection-mediated virus spread across endothelial cell barriers. J. Virol. 82, 11273-11282 (2008).
6. Wang, T. et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10, 1366-1373 (2004).
7. Libbey, J. & Fujinami, R. S. Adaptive immune response to viral infections in the central nervous system. Hanb. Clin. Neurol. 123, 225-247 (2014).
8. Daniels, B. P. et al. Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. mBio 5, e01476-14 (2014).
9. Daniels, B. P. & Klein, R. S. Knocking on closed doors: host interferons dynamically regulate blood-brain barrier function during viral infections of the central nervous system. PLoS Pathog. 11, e1005096 (2015).
10. McGavern, D. B. & Kang, S. S. Illuminating viral infections in the nervous system. Nature 11, 318-329 (2011).
11. Kramer-Hämmerle, S., Rothenaigner, I., Wolff, H., Bell, J. E. & Brack-Werner, R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 111, 194-213 (2005).
12. Kramer, T. & Enquist, L. Directional spread of alphaherpesviruses in the nervous system. Viruses 5, 678-707 (2013).
13. Howard, P. W., Howard, T. L. & Johnson, D. C. Herpes simplex virus membrane proteins gE/gI and US9 act cooperatively to promote transport of capsids and glycoproteins from neuron cell bodies into initial axon segments. J. Virol. 87, 403-414 (2012).
14. Kramer, T. et al. Kinesin3 mediates axonal sorting and directional transport of alphaherpesvirus particles in neurons. Cell Host Microbe 12, 806-814 (2012).
15. Zaichick, S. V. et al. The herpesvirus VP1/2 Protein is an effector of dynein-mediated capsid transport and neuroinvasion. Cell Host Microbe 13, 193-203 (2013).
16. Granstedt, A. E., Brunton, B. W. & Enquist, L. W. Imaging the transport dynamics of single alphaherpesvirus particles in intact peripheral nervous system explants from infected mice. mBio 4, e00358-13 (2013).
17. Hagendorf, N. & Conzelmann, K.K. Recombinant fluorescent rabies virus vectors for tracing neurons and synaptic connections. Cold Spring Harb. Protoc. http://dx.doi.org/10.1101/pdb.top089391 (2015).
18. Flint, J., Racaniello, V., Rall, G. F., Skalka, A. M. & Enquist, L. W. Principles of Virology 4th edn (American Society for Microbiology, 2015).
19. Lawrence, D. M. P. et al. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J. Virol. 74, 1908-1918 (2000).
20. Makhortova, N. R. et al. Neurokinin1 enables measles virus trans-synaptic spread in neurons. Virology 362, 235-244 (2007).
21. Iwasaki, Y., Ohtani, S. & Clark, H. F. Maturation of rabies virus by budding from neuronal cell membrane in suckling mouse brain. J. Virol. 15, 1020-1023 (1975).
22. Wherry, E. J. & Ahmed, R. Memory CD8 Tcell differentiation during viral infection. J. Virol. 78, 5535-5545 (2004).
23. Oldstone, M. B. A. Anatomy of viral persistence. PLoS Pathog. 5, e1000523 (2009).
24. Kinchington, P. R., Leger, A. J. S., Guedon, J.M. G. & Hendricks, R. L. Herpes simplex virus and varicella zoster virus, the house guests who never leave. Herpesviridae 3, 5 (2012).
25. Jiang, X. et al. The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme Binduced apoptosis and CD8 Tcell killing. J. Virol. 85, 2325-2332 (2011).
26. Mohammadi, P., Ciuffi, A. & Beerenwinkel, N. Dynamic models of viral replication and latency. Curr. Opin. HIV AIDS 10, 90-95 (2015).
27. Oldstone, M. B. A. Viral persistence: parameters, mechanisms and future predictions. Virology 344, 111-118 (2006).
28. Traub, E. Persistence of lymphocytic choriomeningitis virus in immune animals and its relation to immunity. J. Exp. Med. 63, 847-861 (1936).
29. Brot, M. D., Rall, G. F., Oldstone, M. B. A., Koob, G. F. & Gold, L. H. Deficits in discriminated learning remain despite clearance of long-term persistent viral infection in mice. J. Neurovirol. 3, 265-273 (1997).
30. Norrby, E. & Kristensson, K. Measles virus in the brain. Brain Res. Bull. 44, 213-220 (1997).
31. Gutierrez, J., Issacson, R. S. & Koppel, B. S. Subacute sclerosing panencephalitis: an update. Dev. Med. Child Neurol. 52, 901-907 (2010).
32. Griffin, D. E. Measles virus and the nervous system. Handb. Clin. Neurol. 123, 577-590 (2014).
33. Griffin, D. E., Lin, W.H. & Pan, C.H. Measles virus, immune control, and persistence. FEMS Microbiol. Rev. 36, 649-662 (2012).
34. Hayashi, M. et al. Neurodegenerative mechanisms in subacute sclerosing panencephalitis. J. Child Neurol. 17, 725-730 (2002).
35. Clarke, P., Beckham, J. D., Leser, J. S., Hoyt, C. C. & Tyler, K. L. Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. J. Virol. 83, 6161-6170 (2009).
36. Berens, H. M. & Tyler, K. L. The proapoptotic Bcl2 protein Bax plays an important role in the pathogenesis of reovirus encephalitis. J. Virol. 85, 3858-3871 (2011).
37. Goodbourn, S., Didcock, L. & Randall, R. E. Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. J. Gen. Virol. 81, 2341-2364 (2000).
38. Delhaye, S. et al. Neurons produce type I interferon during viral encephalitis. Proc. Natl Acad. Sci. USA 103, 7835-7840 (2006).
39. Faul, E. J. et al. Rabies virus infection induces type I interferon production in an IPS1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog. 6, e1001016 (2010).
40. Rose, R. W., Vorobyeva, A. G., Skipworth, J. D., Nicolas, E. & Rall, G. F. Altered levels of STAT1 and STAT3 influence the neuronal response to interferon gamma. J. Neuroimmunol. 192, 145-156 (2007).
41. Cavanaugh, S. E., Holmgren, A. M. & Rall, G. F. Homeostatic interferon expression in neurons is sufficient for early control of viral infection. J. Neuroimmunol. 279, 11-19 (2015).
42. Podolsky, M. A. et al. Extended JAK activation and delayed STAT1 dephosphorylation contribute to the distinct signaling profile of CNS neurons exposed to interferon-gamma. J. Neuroimmunol. 251, 33-38 (2012).
43. Zurney, J., Howard, K. E. & Sherry, B. Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses. J. Virol. 81, 13668-13680 (2007).
44. Rosato, P. C. & Leib, D. A. Neuronal interferon signaling is required for protection against herpes simplex virus replication and pathogenesis. PLoS Pathog. 11, e1005028 (2015).
45. Song, R. et al. Two modes of the axonal interferon response limit alphaherpesvirus neuroinvasion. mBio 7, e02145-15 (2016).
46. Kapil, P., Butchi, N. B., Stohlman, S. A. & Bergmann, C. C. Oligodendroglia are limited in type I interferon induction and responsiveness in vivo. Glia 60, 1555-1566 (2012).
47. Paul, S., Ricour, C., Sommereyns, C., Sorgeloos, F. & Michiels, T. Type I interferon response in the central nervous system. Biochimie 89, 770-778 (2007).
48. Holmgren, A. M., Miller, K. D., Cavanaugh, S. E. & Rall, G. F. Bst2/tetherin is induced in neurons by type I interferon and viral infection but is dispensable for protection against neurotropic viral challenge. J. Virol. 89, 11011-11018 (2015).
49. Ireland, D. D. C., Stohlman, S. A., Hinton, D. R., Atkinson, R. & Bergmann, C. C. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J. Virol. 82, 300-310 (2007).
50. Weber, E. et al. Type I Interferon protects mice from fatal neurotropic infection with langat virus by systemic and local antiviral responses. J. Virol. 88, 12202-12212 (2014).
51. Fensterl, V. et al. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 8, e1002712 (2012).
52. Samuel, M. A. & Diamond, M. S. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79, 13350-13361 (2005).
53. Lobigs, M., Mullbacher, A., Wang, Y., Pavy, M. & Lee, E. Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus. J. Gen. Virol. 84, 567-572 (2003).
54. Nayak, D. et al. Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system. PLoS Pathog. 9, e1003395 (2013).
55. Detje, C. N. et al. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J. Immunol. 182, 2297-2304 (2009).
56. van den Pol, A. N., Ding, S. & Robek, M. D. Longdistance interferon signaling within the brain blocks virus spread. J. Virol. 88, 3695-3704 (2014).
57. Aspelund, A. et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212, 991-999 (2015).
58. Jessen, N. A., Munk, A. S. F., Lundgaard, I. & Nedergaard, M. The glymphatic system: a beginner's guide. Neurochem. Res. 40, 2583-2599 (2015).
59. Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337-341 (2015).
60. Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid. Sci. Transl Med. 4, 147ra111 (2012).
61. Neumann, H., Cavalie, A., Jenne, D. E. & Wekerle, H. Induction of MHC class I genes in neurons. Science 269, 549-552 (2016).
62. Neumann, H., Schmidt, H., Cavalie, A., Jenne, D. & Wekerle, H. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN). J. Exp. Med. 185, 305-316 (1997).
63. Joly, E., Mucke, L. & Oldstone, M. B. A. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253, 1283-1285 (2016).
64. Calzascia, T. et al. Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain. J. Immunol. 171, 2187-2191 (2003).
65. Jeon, S., St Leger, A. J., Cherpes, T. L., Sheridan, B. S. & Hendricks, R. L. PDL1/B7H1 regulates the survival but not the function of CD8+ T cells in herpes simplex virus type 1 latently infected trigeminal ganglia. J. Immunol. 190, 6277-6286 (2013).
66. Huh, G. S. et al. Functional requirement for class I MHC in CNS development and plasticity. Science 290, 2155-2159 (2000).
67. Goddard, C. A., Butts, D. A. & Shatz, C. J. Regulation of CNS synapses by neuronal MHC class I. Proc. Natl Acad. Sci. USA 104, 6828-6833 (2007).
68. O'Donnell, L. A. et al. STAT1independent control of a neurotropic measles virus challenge in primary neurons and infected mice. J. Immunol. 188, 1915-1923 (2012).
69. Burdeinick-Kerr, R., Govindarajan, D. & Griffin, D. E. Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/ Stat Signaling. J. Virol. 83, 3429-3435 (2009).
70. Patterson, C. E., Lawrence, D. M. P., Echols, L. A. & Rall, G. F. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J. Virol. 76, 4497-4506 (2002).
71. Parra, B. et al. IFN-is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162, 1641-1647 (1999).
72. González, J. M. et al. Inhibition of interferon-signaling in oligodendroglia delays coronavirus clearance without altering demyelination. Am. J. Pathol. 168, 796-804 (2006).
73. O'Donnell, L. A. et al. Interferon gamma induces protective non-canonical signaling pathways in primary neurons. J. Neurochem. 135, 309-322 (2015).
74. St Leger, A. J. & Hendricks, R. L. CD8+ T cells patrol HSV1infected trigeminal ganglia and prevent viral reactivation. J. Neurovirol. 17, 528-534 (2011).
75. Liu, T., Khanna, K. M., Chen, X., Fink, D. J. & Hendricks, R. L. CD8+ T cells can block herpes simplex virus type 1 (HSV1) reactivation from latency in sensory neurons. J. Exp. Med. 191, 1459-1466 (2000).
76. Theil, D. et al. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. 163, 2179-2184 (2014).
77. Liu, T., Khanna, K. M., Carriere, B. N. & Hendricks, R. L. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 75, 11178-11184 (2001).
78. Liu, T., Tang, Q. & Hendricks, R. L. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70, 264-271 (1996).
79. Wakim, L. M., Woodward-Davis, A. & Bevan, M. J. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc. Natl Acad. Sci. USA 107, 17872-17879 (2010).
80. Wakim, L. M. et al. The molecular signature of tissue resident memory CD8 T cells isolated from the brain. J. Immunol. 189, 3462-3471 (2012).
81. Park, C. O. & Kupper, T. S. The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat. Med. 21, 688-697 (2015).
82. Knickelbein, J. E. et al. Noncytototoxic lytic granulemediated CD8+ T cell inhibition of HSV1 reactivation from neuronal latency. Science 322, 268-271 (2008).
83. Marcet-Palacios, M. et al. Granzyme B inhibits vaccinia virus production through proteolytic cleavage of eukaryotic initiation factor 4 gamma 3. PLoS Pathog. 7, e1002447 (2011).
84. Himmelein, S. et al. Latent herpes simplex virus 1 infection does not induce apoptosis in human trigeminal ganglia. J. Virol. 89, 5747-5750 (2011).
85. Howe, C. L. et al. Hippocampal protection in mice with an attenuated inflammatory monocyte response to acute CNS picornavirus infection. Sci. Rep. 2, 545 (2012).
86. Phares, T., Stohlman, S. & Bergmann, C. Intrathecal humoral immunity to encephalitic RNA viruses. Viruses 5, 732-752 (2013).
87. Skoldenberg, B., Kalimo, K., Carlstrom, A., Forgren, M. & Halonen, P. Herpes simplex encephalitis: a serological follow up study. Acta Neuropathol. 63, 273-285 (1981).
88. Burke, D. S., Nisalak, A., Lorsomrudee, W., Ussery, M. A. & Laorpongse, T. Virus-specific antibody producing cells in blood and cerebrospinal fluid in acute Japanese encephalitis. J. Med. Virol. 17, 283-292 (1985).
89. Cho, H. et al. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positivestranded RNA viruses. Nat. Med. 19, 458-464 (2013).
90. Jehmlich, U., Ritzer, J., Grosche, J., Härtig, W. & Liebert, U. G. Experimental measles encephalitis in Lewis rats: dissemination of infected neuronal cell subtypes. J. Neurovirol. 19, 461-470 (2013).
91. Liebert, U. G., Baczko, K., Budka, H. & ter Meulen, V. Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J. Gen. Virol. 67, 2435-2444 (1986).
92. Backzo, K. et al. Restriction of measles virus gene expression in measles inclusion body encephalitis. J. Infect. Dis. 158, 144-150 (1988).
93. Zerboni, L. & Arvin, A. Neuronal subtype and satellite cell tropism are determinants of varicellazoster virus virulence in human dorsal root ganglia xenografts in vivo. PLoS Pathog. 11, e1004989 (2015).
94. Lucas, T. M., Richner, J. M. & Diamond, M. S. The interferon-stimulated gene Ifi27l2a restricts West Nile virus infection and pathogenesis in a cell-type and region-specific manner. J. Virol. 90, 2600-2615 (2015).
95. Gomme, E. A., Wirblich, C., Addya, S., Rall, G. F. & Schnell, M. J. Immune clearance of attenuated rabies virus results in neuronal survival with altered gene expression. PLoS Pathog. 8, e1002971 (2012).
96. Katayama, Y. et al. Detection of measles virus mRNA from autopsied human tissues. J. Clin. Microbiol. 36, 299-301 (1998).
97. Nakayama, T. et al. Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus Res. 35, 1-16 (1995).
98. Kawashima, H. et al. A case of intractable epilepsy positive for the detection of measles virus genome in the cerebrospinal fluid and peripheral mononuclearcells using reverse transcriptasepolymerase chain reaction. Brain Dev. 18, 220-223 (1996).
99. Haase, A. T. et al. Natural history of restricted synthesis and expression of measles virus genes in subacute sclerosing panencephalitis. Proc. Natl Acad. Sci. USA 82, 3020-3024 (1985).
100. Katayama, Y., Hotto, H., Nishimura, A., Tatsuno, Y. & Homma, M. Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. J. Gen. Virol. 76, 3201-3204 (1995).
101. Hanninen, P., Arstila, P., Lang, H., Salmi, A. & Panelius, M. Involvement of the central nervous system in acute, uncomplicated measles virus infection. J. Clin. Microbiol. 11, 610-613 (1980).
102. Allen, I. V., McQuaid, S., McMahon, J., Kirk, J. & McConnell, R. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanims of viral spread and demyelination. J. Neuropathol. Exp. Neurol. 55, 471-480 (1996).
103. Matthews, A. E. et al. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. J. Immunol. 167, 5254-5263 (2001).
104. Lavi, E., Gilden, D. H., Hihkin, M. K. & Weiss, S. Persistence of mouse hepatits virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybriization. J. Virol. 51, 563-566 (1984).
105. Koch, E. M., Neubert, W. J. & Hofschneider, P. H. Lifelong persistence of paramyxovirus Sendai6/94 in C129 mice: detection of latent viral RNA by hybridization with a cloned genomic cDNA probe. Virology 136, 78-88 (1984).
106. Griffin, D. E. & Levine, B. Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J. Virol. 66, 6429-6435 (1992).
107. Li, W. et al. Human endogenous retrovirusK contributes to motor neuron disease. Sci. Transl Med. 7, 307ra153 (2015).
108. Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro-preliminary report. N. Engl. J. Med. http://dx.doi.org/10.1056/NEJMoa1602412 (2016).
109. Rasmussen, S. A., Jamieson, D. J., Honein, M. A. & Petersen, L. R. Zika virus and birth defects-reviewing the evidence for causality. N. Engl. J. Med. 374, 1981-1987 (2016).
110. Wiley, C. A., Bhardwaj, N., Ross, T. M. & Bissel, S. J. Emerging Infections of CNS: avian influenza A virus, Rift Valley fever virus and human parechovirus. Brain Pathol. 25, 634-650 (2015).
111. Söderberg-Nauclér, C. & Johnsen, J. I. Cytomegalovirus in human brain tumors: role in pathogenesis and potential treatment options. WJEM 5, 1-10 (2015).
112. Sudhakar, P., Bachman, D. M., Mark, A. S., Berger, J. R. & Kedar, S. Progressive multifocal leukoencephalopathy. J. Neuroophthamol. 35, 296-305 (2015).
113. Maehlen, J., Wallen, P., Love, A., Norrby, E. & Kristensson, K. Paramyxovirus infections alter certain functional properties in cultured sensory neurons. Brain Res. 540, 123-130 (1991).
114. Zhong, P., Agosto, L. M., Munro, J. B. & Mothes, W. Celltocell transmission of viruses. Curr. Opin. Virol. 3, 44-50 (2013).
115. Watanabe, S. et al. Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology. J. Virol. 89, 2710-2717 (2015).
116. Taylor, M. P., Kobiler, O. & Enquist, L. W. Alphaherpesvirus axontocell spread involves limited virion transmission. Proc. Natl Acad. Sci. USA 109, 17046-17051 (2012).
117. Lancaster, K. Z. & Pfeiffer, J. K. Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response. PLoS Pathog. 6, e1000791 (2010).
118. Sattentau, Q. Avoiding the void: celltocell spread of human viruses. Nat. Rev. Microbiol. 6, 815-826 (2008).